Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Platform Trials Could Be A Solution To Expanded Access, Woodcock Says

Jan 23 2019

• By Michael Cipriano

A group of people in the shape of tag, medicine, flash mob.

Related Content

Right-To-Try Legislation Must Change Language To Narrow Spectrum Of Patients, Gottlieb Says

Oct 04 2017

FDA's Gottlieb Pushing 'Seamless' Clinical Trials For Faster Development

Sep 12 2017

Master Protocols In Practice

Jul 07 2017

Woodcock Hopes I-SPY 2 Trial Is 'Blazing The Trail' For Future Adaptive Design Uptake

Sep 13 2018

“One Continuous Trial” In Oncology: US FDA Offers Guidance And Encouragement

Aug 22 2018

Expanded Access Data Supported Lutathera Approval, US FDA Notes

Jan 29 2018

US FDA's Gottlieb Touts 'Seamless' Clinical Trials, Worries About Second-To-Market Products

Jul 26 2018

Additional Topics

United States Clinical Trials Rare Diseases Regulation BioPharmaceutical

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window